Jory Capital

Jory Capital is a Canadian investment firm dedicated to advancing the development of transformative companies and next-generation leaders. With a focus on health and human performance, the firm seeks to inspire innovation, change, and growth to lead the future of the world's health and human potential. Their investment strategy is customized and purposeful, emphasizing long-term relationships and connections that hold the potential to create meaningful change. By supporting and connecting the strategic visions of company leaders, Jory Capital aims to build strong operators and inspire cultures for a better tomorrow. As health and human performance experts, they are purposefully built to recognize market opportunities and accelerate businesses through strategic investment and proven governance advisory services. Their investments include companies such as HC9 Ventures, Human Powered Health, and Vytalize Health, reflecting their commitment to sectors that align with their mission. The team comprises experienced professionals, including co-founders David S. Wichmann and Anne T. Wichmann, Managing Directors Bradley Melnick and Gabrielle Mosher, and Chief of Portfolio Operations Kevin Knarr, among others. Together, they work to empower leaders and teams to achieve their collective potential and impact, generating results that matter for society and investors.